Recall Register

Food, drugs, devices › Actavis Elizabeth LLC

Drug recall: NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 E

FDA enforcement event 75445 · Class III · initiated 6 Oct 2016 · status Terminated · terminated 8 May 2017

DrugVoluntary: Firm initiated1 product recordElizabeth, NJ

Actavis Elizabeth LLC (Elizabeth, NJ) initiated this drug recall on 6 Oct 2016; FDA lists 1 product record under event 75445, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 43% of the 288 drug enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 8 May 2017. Initiation: voluntary: firm initiated. Actavis Elizabeth LLC has 9 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Actavis Elizabeth LLC, Elizabeth, NJ.

Reason for recall

"Presence of Foreign Tablets/Capsules"

Distribution

"US"

Product records

Recall numberProductQuantityClassStatusReport date
D-0143-2017NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-2407-1027,517 bottlesClass IIITerminated30 Nov 2016

Context

43%of 2016 drug events are Class III288 events that year
1product record in this eventfirm median: 1
9events on this register for the firm

Other enforcement events for Actavis Elizabeth LLC

InitiatedProduct (first record)TypeClassRecords
16 Feb 2016Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 10 mg, DrugClass II4
10 Feb 2015Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis ElizabetDrugClass II1
15 Dec 2014Gabapentin Capsules, USP, 400 mg, Rx Only, a) 100 capsules per bottle, NDC 14550-513-02, b) 500 Capsules per bottle, NDCDrugClass II3
10 Feb 2014Alprazolam 1 mg Tablets, USP, 500 count Bottle, Rx Only , C IV, Manufactured by: Actavis Elizabeth LLC 200 Elmora AvenueDrugClass II1
4 Feb 2014Alprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle, Rx only, Manufactured by: Actavis ElizabethDrugClass II1
6 Nov 2013Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USDrugClass II1
9 Oct 2013Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., ElizabetDrugClass II1
13 Feb 2013Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate ExtendedDrugClass III1

All 9 events for Actavis Elizabeth LLC

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Presence of Foreign Tablets/Capsules"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "US"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 8 May 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.